Seo Joann, Ivanovich Jennifer, Goodman Melody S, Biesecker Barbara B, Kaphingst Kimberly A
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8100, St. Louis, MO, 63110, USA.
Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, MD, USA.
J Genet Couns. 2017 Jun;26(3):511-521. doi: 10.1007/s10897-016-0006-2. Epub 2016 Aug 20.
We investigated what information women diagnosed with breast cancer at a young age would want to learn when genome sequencing results are returned. We conducted 60 semi-structured interviews with women diagnosed with breast cancer at age 40 or younger. We examined what specific information participants would want to learn across result types and for each type of result, as well as how much information they would want. Genome sequencing was not offered to participants as part of the study. Two coders independently coded interview transcripts; analysis was conducted using NVivo10. Across result types, participants wanted to learn about health implications, risk and prevalence in quantitative terms, causes of variants, and causes of diseases. Participants wanted to learn actionable information for variants affecting risk of preventable or treatable disease, medication response, and carrier status. The amount of desired information differed for variants affecting risk of unpreventable or untreatable disease, with uncertain significance, and not health-related. Women diagnosed with breast cancer at a young age recognize the value of genome sequencing results in identifying potential causes and effective treatments and expressed interest in using the information to help relatives and to further understand their other health risks. Our findings can inform the development of effective feedback strategies for genome sequencing that meet patients' information needs and preferences.
我们调查了年轻时被诊断出患有乳腺癌的女性在收到基因组测序结果时想要了解哪些信息。我们对60名年龄在40岁及以下且被诊断出患有乳腺癌的女性进行了半结构化访谈。我们研究了参与者在不同结果类型中以及针对每种结果类型想要了解哪些具体信息,以及她们想要了解多少信息。基因组测序并非作为研究的一部分提供给参与者。两名编码员独立对访谈记录进行编码;使用NVivo10进行分析。在不同结果类型中,参与者希望了解健康影响、定量的风险和患病率、变异的原因以及疾病的病因。对于影响可预防或可治疗疾病风险、药物反应和携带者状态的变异,参与者希望了解可采取行动的信息。对于影响不可预防或不可治疗疾病风险、意义不确定且与健康无关的变异,所需信息的数量有所不同。年轻时被诊断出患有乳腺癌的女性认识到基因组测序结果在识别潜在病因和有效治疗方法方面的价值,并表示有兴趣利用这些信息帮助亲属并进一步了解自己的其他健康风险。我们的研究结果可为制定满足患者信息需求和偏好的基因组测序有效反馈策略提供参考。